SCHEMBL4154118

SCHEMBL4154118

C=CCSc1ccc(N(C)C(=O)NC(=O)c2c(F)cccc2F)c(F)c1

nearest known ligand 0.33

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.33
ATM Q13315 1/20 0.33
TDP1 Q9NUW8 1/20 0.32
RORC P51449 1/20 0.32
MEN1 O00255 4/20 0.31
KMT2A Q03164 4/20 0.31
TRPA1 O75762 2/20 0.31
RAB9A P51151 3/20 0.31
NPC1 O15118 2/20 0.31
PPIA P62937 1/20 0.31
PKM P14618 1/20 0.31
IL2 P60568 1/20 0.30
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30
MAPT P10636 1/20 0.30
HPGD P15428 1/20 0.30
HTT P42858 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4637621 0.89 CES2 (0.32)
SCHEMBL4149973 0.88 RORC (0.33) TDP1RORCMEN1KMT2ATRPA1
SCHEMBL4157453 0.87 TRPA1 (0.36) ATMTDP1RORCMEN1KMT2A
SCHEMBL4160195 0.84 TRPA1 (0.35) ATMRORCMEN1KMT2ATRPA1
SCHEMBL4154199 0.83 RAB9A (0.38) ATMTDP1RORCMEN1KMT2A
SCHEMBL4150582 0.83 RORC (0.34) ATMRORCMEN1KMT2ATRPA1
SCHEMBL4159023 0.83 RORC (0.35) L3MBTL1TDP1RORCKDM4EMAPT
SCHEMBL4148300 0.82 ATM (0.45) ATMTDP1RORCMEN1KMT2A
SCHEMBL4158996 0.80 TRPA1 (0.34) ATMRORCMEN1KMT2ATRPA1
SCHEMBL4154465 0.80 RORC (0.41) L3MBTL1RORCKMT2ARAB9APPIA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
EP-1937629-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-07-02 EP disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 L3MBTL1 8/4885ATM 2385/4885TDP1 1690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.